Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLXA4-ME Oral Rinse for Gingivitis
NCT02342691Phase 2Completed
- Sponsor
- ADA Forsyth Institute
- Start
- Apr 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of benzo-lipoxin A4 methyl ester in gingivitis (3 arms), sponsored by ADA Forsyth Institute. Primary endpoint: Incidence of Adverse Events at 90 days. Started Apr 2015; status: completed.
02
Drugs
benzo-lipoxin A4 methyl ester
03
Conditions
gingivitis
Beyond the preview
Go deeper on NCT02342691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02342691.